カテゴリー： LP Information, 世界, 医療/バイオ

世界のゴナドトロピン放出ホルモン拮抗薬市場予測 2021年-2026年

【英語タイトル】Global Gonadotropin-releasing Hormone Antagonists Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9544）・商品コード：LPI21MY9544
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：131
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「ゴナドトロピン放出ホルモン拮抗薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ペプチド、小分子など、用途別には、前立腺がん、子宮内膜症、子宮筋腫、女性不妊症、その他などにセグメント区分してまとめました。ゴナドトロピン放出ホルモン拮抗薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・ゴナドトロピン放出ホルモン拮抗薬の世界市場概要（サマリー）
・ゴナドトロピン放出ホルモン拮抗薬の企業別販売量・売上
・ゴナドトロピン放出ホルモン拮抗薬の企業別市場シェア
・ゴナドトロピン放出ホルモン拮抗薬の世界市場規模 2016年-2021年：種類別（ペプチド、小分子）
・ゴナドトロピン放出ホルモン拮抗薬の世界市場規模 2016年-2021年：用途別（前立腺がん、子宮内膜症、子宮筋腫、女性不妊症、その他）
・ゴナドトロピン放出ホルモン拮抗薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・ゴナドトロピン放出ホルモン拮抗薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・ゴナドトロピン放出ホルモン拮抗薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・ゴナドトロピン放出ホルモン拮抗薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・ゴナドトロピン放出ホルモン拮抗薬市場の成長要因・課題・動向
・ゴナドトロピン放出ホルモン拮抗薬の世界市場予測 2021年-2026年
・ゴナドトロピン放出ホルモン拮抗薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・ゴナドトロピン放出ホルモン拮抗薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・ゴナドトロピン放出ホルモン拮抗薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・ゴナドトロピン放出ホルモン拮抗薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・ゴナドトロピン放出ホルモン拮抗薬の世界市場予測：種類別（ペプチド、小分子）
・ゴナドトロピン放出ホルモン拮抗薬の世界市場予測：用途別（前立腺がん、子宮内膜症、子宮筋腫、女性不妊症、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Gonadotropin-releasing Hormone Antagonists will have significant change from previous year. By the most conservative estimates of global Gonadotropin-releasing Hormone Antagonists market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Gonadotropin-releasing Hormone Antagonists market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Gonadotropin-releasing Hormone Antagonists market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Peptides
Small Molecules

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Prostate Cancer
Endometriosis
Uterine Fibroids
Female Infertility
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
AbbVie
Takeda
Astellas
Kissei
Veru Inc
Myovant Sciences
AstraZeneca
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gonadotropin-releasing Hormone Antagonists Consumption 2016-2026
2.1.2 Gonadotropin-releasing Hormone Antagonists Consumption CAGR by Region
2.2 Gonadotropin-releasing Hormone Antagonists Segment by Type
2.2.1 Peptides
2.2.2 Small Molecules
2.3 Gonadotropin-releasing Hormone Antagonists Sales by Type
2.3.1 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2016-2021)
2.3.2 Global Gonadotropin-releasing Hormone Antagonists Revenue and Market Share by Type (2016-2021)
2.3.3 Global Gonadotropin-releasing Hormone Antagonists Sale Price by Type (2016-2021)
2.4 Gonadotropin-releasing Hormone Antagonists Segment by Application
2.4.1 Prostate Cancer
2.4.2 Endometriosis
2.4.3 Uterine Fibroids
2.4.4 Female Infertility
2.4.5 Others
2.5 Gonadotropin-releasing Hormone Antagonists Sales by Application
2.5.1 Global Gonadotropin-releasing Hormone Antagonists Sale Market Share by Application (2016-2021)
2.5.2 Global Gonadotropin-releasing Hormone Antagonists Revenue and Market Share by Application (2016-2021)
2.5.3 Global Gonadotropin-releasing Hormone Antagonists Sale Price by Application (2016-2021)

3 Global Gonadotropin-releasing Hormone Antagonists by Company
3.1 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Company
3.1.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Company (2019-2021)
3.1.2 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Company (2019-2021)
3.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Company
3.2.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Company (2019-2021)
3.2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Company (2019-2021)
3.3 Global Gonadotropin-releasing Hormone Antagonists Sale Price by Company
3.4 Global Manufacturers Gonadotropin-releasing Hormone Antagonists Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gonadotropin-releasing Hormone Antagonists Product Location Distribution
3.4.2 Players Gonadotropin-releasing Hormone Antagonists Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Gonadotropin-releasing Hormone Antagonists by Region
4.1 Global Gonadotropin-releasing Hormone Antagonists by Region
4.1.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Region
4.1.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region
4.2 Americas Gonadotropin-releasing Hormone Antagonists Sales Growth
4.3 APAC Gonadotropin-releasing Hormone Antagonists Sales Growth
4.4 Europe Gonadotropin-releasing Hormone Antagonists Sales Growth
4.5 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Growth

5 Americas
5.1 Americas Gonadotropin-releasing Hormone Antagonists Sales by Country
5.1.1 Americas Gonadotropin-releasing Hormone Antagonists Sales by Country (2016-2021)
5.1.2 Americas Gonadotropin-releasing Hormone Antagonists Revenue by Country (2016-2021)
5.2 Americas Gonadotropin-releasing Hormone Antagonists Sales by Type
5.3 Americas Gonadotropin-releasing Hormone Antagonists Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Gonadotropin-releasing Hormone Antagonists Sales by Region
6.1.1 APAC Gonadotropin-releasing Hormone Antagonists Sales by Region (2016-2021)
6.1.2 APAC Gonadotropin-releasing Hormone Antagonists Revenue by Region (2016-2021)
6.2 APAC Gonadotropin-releasing Hormone Antagonists Sales by Type
6.3 APAC Gonadotropin-releasing Hormone Antagonists Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Gonadotropin-releasing Hormone Antagonists by Country
7.1.1 Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2016-2021)
7.1.2 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2016-2021)
7.2 Europe Gonadotropin-releasing Hormone Antagonists Sales by Type
7.3 Europe Gonadotropin-releasing Hormone Antagonists Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Gonadotropin-releasing Hormone Antagonists by Country
8.1.1 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2016-2021)
8.1.2 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country (2016-2021)
8.2 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Type
8.3 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Gonadotropin-releasing Hormone Antagonists Distributors
10.3 Gonadotropin-releasing Hormone Antagonists Customer

11 Global Gonadotropin-releasing Hormone Antagonists Market Forecast
11.1 Global Gonadotropin-releasing Hormone Antagonists Forecast by Region
11.1.1 Global Gonadotropin-releasing Hormone Antagonists Forecast by Regions (2021-2026)
11.2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Gonadotropin-releasing Hormone Antagonists Forecast by Type
11.7 Global Gonadotropin-releasing Hormone Antagonists Forecast by Application

12 Key Players Analysis
12.1 AbbVie
12.1.1 AbbVie Company Information
12.1.2 AbbVie Gonadotropin-releasing Hormone Antagonists Product Offered
12.1.3 AbbVie Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 AbbVie Main Business Overview
12.1.5 AbbVie Latest Developments
12.2 Takeda
12.2.1 Takeda Company Information
12.2.2 Takeda Gonadotropin-releasing Hormone Antagonists Product Offered
12.2.3 Takeda Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Takeda Main Business Overview
12.2.5 Takeda Latest Developments
12.3 Astellas
12.3.1 Astellas Company Information
12.3.2 Astellas Gonadotropin-releasing Hormone Antagonists Product Offered
12.3.3 Astellas Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Astellas Main Business Overview
12.3.5 Astellas Latest Developments
12.4 Kissei
12.4.1 Kissei Company Information
12.4.2 Kissei Gonadotropin-releasing Hormone Antagonists Product Offered
12.4.3 Kissei Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Kissei Main Business Overview
12.4.5 Kissei Latest Developments
12.5 Veru Inc
12.5.1 Veru Inc Company Information
12.5.2 Veru Inc Gonadotropin-releasing Hormone Antagonists Product Offered
12.5.3 Veru Inc Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Veru Inc Main Business Overview
12.5.5 Veru Inc Latest Developments
12.6 Myovant Sciences
12.6.1 Myovant Sciences Company Information
12.6.2 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Offered
12.6.3 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Myovant Sciences Main Business Overview
12.6.5 Myovant Sciences Latest Developments
12.7 AstraZeneca
12.7.1 AstraZeneca Company Information
12.7.2 AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Offered
12.7.3 AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 AstraZeneca Main Business Overview
12.7.5 AstraZeneca Latest Developments
12.8 Ferring Pharmaceuticals
12.8.1 Ferring Pharmaceuticals Company Information
12.8.2 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Offered
12.8.3 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Ferring Pharmaceuticals Main Business Overview
12.8.5 Ferring Pharmaceuticals Latest Developments
12.9 Jiangsu Hengrui Medicine Co
12.9.1 Jiangsu Hengrui Medicine Co Company Information
12.9.2 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Offered
12.9.3 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Jiangsu Hengrui Medicine Co Main Business Overview
12.9.5 Jiangsu Hengrui Medicine Co Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Gonadotropin-releasing Hormone Antagonists Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Peptides
Table 3. Major Players of Small Molecules
Table 4. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2016-2021) & (K Units)
Table 5. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2016-2021)
Table 6. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2016-2021) & ($ million)
Table 7. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2016-2021)
Table 8. Global Gonadotropin-releasing Hormone Antagonists Sale Price by Type (2016-2021)
Table 9. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2016-2021) & (K Units)
Table 10. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2016-2021)
Table 11. Global Gonadotropin-releasing Hormone Antagonists Value by Application (2016-2021)
Table 12. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2016-2021)
Table 13. Global Gonadotropin-releasing Hormone Antagonists Sale Price by Application (2016-2021)
Table 14. Global Gonadotropin-releasing Hormone Antagonists Sales by Company (2019-2021) & (K Units)
Table 15. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Company (2019-2021)
Table 16. Global Gonadotropin-releasing Hormone Antagonists Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Company (2019-2021)
Table 18. Global Gonadotropin-releasing Hormone Antagonists Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Gonadotropin-releasing Hormone Antagonists Producing Area Distribution and Sales Area
Table 20. Players Gonadotropin-releasing Hormone Antagonists Products Offered
Table 21. Gonadotropin-releasing Hormone Antagonists Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2016-2021) (K Units)
Table 25. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2016-2021)
Table 26. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2016-2021)
Table 28. Americas Gonadotropin-releasing Hormone Antagonists Sales by Country (2016-2021) & (K Units)
Table 29. Americas Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2016-2021)
Table 30. Americas Gonadotropin-releasing Hormone Antagonists Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2016-2021)
Table 32. Americas Gonadotropin-releasing Hormone Antagonists Sales by Type (2016-2021) & (K Units)
Table 33. Americas Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2016-2021)
Table 34. Americas Gonadotropin-releasing Hormone Antagonists Sales by Application (2016-2021) & (K Units)
Table 35. Americas Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2016-2021)
Table 36. APAC Gonadotropin-releasing Hormone Antagonists Sales by Region (2016-2021) & (K Units)
Table 37. APAC Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2016-2021)
Table 38. APAC Gonadotropin-releasing Hormone Antagonists Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2016-2021)
Table 40. APAC Gonadotropin-releasing Hormone Antagonists Sales by Type (2016-2021) & (K Units)
Table 41. APAC Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2016-2021)
Table 42. APAC Gonadotropin-releasing Hormone Antagonists Sales by Application (2016-2021) & (K Units)
Table 43. APAC Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2016-2021)
Table 44. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2016-2021) & (K Units)
Table 45. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2016-2021)
Table 46. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2016-2021)
Table 48. Europe Gonadotropin-releasing Hormone Antagonists Sales by Type (2016-2021) & (K Units)
Table 49. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2016-2021)
Table 50. Europe Gonadotropin-releasing Hormone Antagonists Sales by Application (2016-2021) & (K Units)
Table 51. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Gonadotropin-releasing Hormone Antagonists
Table 61. Key Application and Potential Industries of Gonadotropin-releasing Hormone Antagonists
Table 62. Key Challenges of Gonadotropin-releasing Hormone Antagonists
Table 63. Key Trends of Gonadotropin-releasing Hormone Antagonists
Table 64. Gonadotropin-releasing Hormone Antagonists Distributors List
Table 65. Gonadotropin-releasing Hormone Antagonists Customer List
Table 66. Global Gonadotropin-releasing Hormone Antagonists Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Gonadotropin-releasing Hormone Antagonists Consumption Market Forecast by Region
Table 68. Global Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Gonadotropin-releasing Hormone Antagonists Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Gonadotropin-releasing Hormone Antagonists Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Gonadotropin-releasing Hormone Antagonists Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Gonadotropin-releasing Hormone Antagonists Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Gonadotropin-releasing Hormone Antagonists Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Gonadotropin-releasing Hormone Antagonists Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share Forecast by Application (2021-2026)
Table 86. AbbVie Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 87. AbbVie Gonadotropin-releasing Hormone Antagonists Product Offered
Table 88. AbbVie Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 89. AbbVie Main Business
Table 90. AbbVie Latest Developments
Table 91. Takeda Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 92. Takeda Gonadotropin-releasing Hormone Antagonists Product Offered
Table 93. Takeda Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 94. Takeda Main Business
Table 95. Takeda Latest Developments
Table 96. Astellas Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 97. Astellas Gonadotropin-releasing Hormone Antagonists Product Offered
Table 98. Astellas Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 99. Astellas Main Business
Table 100. Astellas Latest Developments
Table 101. Kissei Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 102. Kissei Gonadotropin-releasing Hormone Antagonists Product Offered
Table 103. Kissei Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 104. Kissei Main Business
Table 105. Kissei Latest Developments
Table 106. Veru Inc Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 107. Veru Inc Gonadotropin-releasing Hormone Antagonists Product Offered
Table 108. Veru Inc Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 109. Veru Inc Main Business
Table 110. Veru Inc Latest Developments
Table 111. Myovant Sciences Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 112. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Offered
Table 113. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 114. Myovant Sciences Main Business
Table 115. Myovant Sciences Latest Developments
Table 116. AstraZeneca Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 117. AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Offered
Table 118. AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 119. AstraZeneca Main Business
Table 120. AstraZeneca Latest Developments
Table 121. Ferring Pharmaceuticals Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 122. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Offered
Table 123. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 124. Ferring Pharmaceuticals Main Business
Table 125. Ferring Pharmaceuticals Latest Developments
Table 126. Jiangsu Hengrui Medicine Co Basic Information, Gonadotropin-releasing Hormone Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 127. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Offered
Table 128. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 129. Jiangsu Hengrui Medicine Co Main Business
Table 130. Jiangsu Hengrui Medicine Co Latest Developments
List of Figures
Figure 1. Picture of Gonadotropin-releasing Hormone Antagonists
Figure 2. Gonadotropin-releasing Hormone Antagonists Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gonadotropin-releasing Hormone Antagonists Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Gonadotropin-releasing Hormone Antagonists Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Peptides
Figure 10. Product Picture of Small Molecules
Figure 11. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type in 2020
Figure 12. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2016-2021)
Figure 13. Gonadotropin-releasing Hormone Antagonists Consumed in Prostate Cancer
Figure 14. Global Gonadotropin-releasing Hormone Antagonists Market: Prostate Cancer (2016-2021) & (K Units)
Figure 15. Gonadotropin-releasing Hormone Antagonists Consumed in Endometriosis
Figure 16. Global Gonadotropin-releasing Hormone Antagonists Market: Endometriosis (2016-2021) & (K Units)
Figure 17. Gonadotropin-releasing Hormone Antagonists Consumed in Uterine Fibroids
Figure 18. Global Gonadotropin-releasing Hormone Antagonists Market: Uterine Fibroids (2016-2021) & (K Units)
Figure 19. Gonadotropin-releasing Hormone Antagonists Consumed in Female Infertility
Figure 20. Global Gonadotropin-releasing Hormone Antagonists Market: Female Infertility (2016-2021) & (K Units)
Figure 21. Gonadotropin-releasing Hormone Antagonists Consumed in Others
Figure 22. Global Gonadotropin-releasing Hormone Antagonists Market: Others (2016-2021) & (K Units)
Figure 23. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2016-2021)
Figure 24. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application in 2020
Figure 25. Gonadotropin-releasing Hormone Antagonists Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Company in 2020
Figure 27. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Regions (2016-2021)
Figure 28. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region in 2020
Figure 29. Americas Gonadotropin-releasing Hormone Antagonists Sales 2016-2021 (K Units)
Figure 30. Americas Gonadotropin-releasing Hormone Antagonists Revenue 2016-2021 ($ Millions)
Figure 31. APAC Gonadotropin-releasing Hormone Antagonists Sales 2016-2021 (K Units)
Figure 32. APAC Gonadotropin-releasing Hormone Antagonists Revenue 2016-2021 ($ Millions)
Figure 33. Europe Gonadotropin-releasing Hormone Antagonists Sales 2016-2021 (K Units)
Figure 34. Europe Gonadotropin-releasing Hormone Antagonists Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales 2016-2021 (K Units)
Figure 36. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue 2016-2021 ($ Millions)
Figure 37. Americas Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country in 2020
Figure 38. Americas Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country in 2020
Figure 39. Americas Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type in 2020
Figure 40. Americas Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application in 2020
Figure 41. United States Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region in 2020
Figure 46. APAC Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Regions in 2020
Figure 47. APAC Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type in 2020
Figure 48. APAC Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application in 2020
Figure 49. China Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country in 2020
Figure 56. Europe Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country in 2020
Figure 57. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type in 2020
Figure 58. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application in 2020
Figure 59. Germany Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application in 2020
Figure 68. Egypt Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Gonadotropin-releasing Hormone Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles


★調査レポート[世界のゴナドトロピン放出ホルモン拮抗薬市場予測 2021年-2026年] (コード：LPI21MY9544)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のゴナドトロピン放出ホルモン拮抗薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のオキシトシン受容体拮抗薬市場予測 2021年-2026年
    LPI21MY2128 / LP Information / 2021年5月 / LPインフォメーション社の「オキシトシン受容体拮抗薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、非ペプチド＆経口活性オキシトシン受容体拮抗薬、高親和性ヒトオキシトシン（OT）受容体拮抗薬など、用途別には、動物、人などにセグメント区分してまとめました。オキシトシン受容体拮抗薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・オキシトシン受容体拮抗薬の世界市場概要（サマリー） ・オキシトシン受容体拮抗薬の企業別販売量・売上 ・オキシトシン受容体拮抗薬の企業別市場シェア ・オキシトシン受容体拮抗薬の世界市場規模 2016年-2021年：種類別（非ペプチド＆経口活性オキシトシン受容体拮抗薬、高親和性ヒトオキシトシン（OT）受容体拮抗薬） ・オキシトシン受容体拮抗薬の世界市場規模 2016年-2021年：用途別（動物、人） ・オキシトシン受容体拮抗薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・オキシトシン受容体拮抗薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Oxytocin Receptor Antagonists will have significant change from previous year. By the most conservative estimates of global Oxytocin Receptor Antagonists market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Oxytocin Receptor Antagonists market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Oxytocin Receptor Antagonists market by product type,...
  • 世界の成長ホルモン薬市場予測 2021年-2026年
    LPI21MY9546 / LP Information / 2021年5月 / LPインフォメーション社の「成長ホルモン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ノルディトロピン、ジェノトロピン、フマトロープ、サイゼン、ニュートロピンなど、用途別には、小売薬局、病院薬局、オンライン薬局などにセグメント区分してまとめました。成長ホルモン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・成長ホルモン薬の世界市場概要（サマリー） ・成長ホルモン薬の企業別販売量・売上 ・成長ホルモン薬の企業別市場シェア ・成長ホルモン薬の世界市場規模 2016年-2021年：種類別（ノルディトロピン、ジェノトロピン、フマトロープ、サイゼン、ニュートロピン） ・成長ホルモン薬の世界市場規模 2016年-2021年：用途別（小売薬局、病院薬局、オンライン薬局） ・成長ホルモン薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・成長ホルモン薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Growth Hormone Drug will have significant change from previous year. By the most conservative estimates of global Growth Hormone Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Growth Hormone Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Growth Hormone Drug market by product type,...
  • 世界の制吐剤市場予測 2021年-2026年
    LPI21MY9416 / LP Information / 2021年5月 / LPインフォメーション社の「制吐剤の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、5-HT3受容体拮抗薬、ドーパミン拮抗薬、NK1受容体拮抗薬、抗ヒスタミン薬（H1ヒスタミン受容体拮抗薬）、カンナビノイド、ベンゾジアゼピン、抗コリン作用薬、ステロイド、その他など、用途別には、化学療法、乗り物酔い、胃腸炎、全身麻酔薬、オピオイド鎮痛薬、眩暈、妊娠、食中毒、情緒的ストレスなどにセグメント区分してまとめました。制吐剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・制吐剤の世界市場概要（サマリー） ・制吐剤の企業別販売量・売上 ・制吐剤の企業別市場シェア ・制吐剤の世界市場規模 2016年-2021年：種類別（5-HT3受容体拮抗薬、ドーパミン拮抗薬、NK1受容体拮抗薬、抗ヒスタミン薬（H1ヒスタミン受容体拮抗薬）、カンナビノイド、ベンゾジアゼピン、抗コリン作用薬、ステロイド、その他） ・制吐剤の世界市場規模 2016年-2021年：用途別（化学療法、乗り物酔い、胃腸炎、全身麻酔薬、オピオイド鎮痛薬、眩暈、妊娠、食中毒、情緒的ストレス） ・制吐剤の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・制吐剤のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Antiemetics will have significant change from previous year. By the most conservative estimates of global Antiemetics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 3733.8 million in 2019. Over the next five years the Antiemetics market will register a 3.8% CAGR in terms of revenue, the global market size will reach US$ 4338.4 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Antiemetics market by product type, application, key manufacturers and key regions and countries....
  • 世界の自己投与薬市場予測 2021年-2026年
    LPI21MY9572 / LP Information / 2021年5月 / LPインフォメーション社の「自己投与薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、注射薬、吸入薬、経皮吸収薬など、用途別には、心血管疾患、糖尿病、骨粗鬆症、疼痛管理、ホルモン補充療法、その他などにセグメント区分してまとめました。自己投与薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・自己投与薬の世界市場概要（サマリー） ・自己投与薬の企業別販売量・売上 ・自己投与薬の企業別市場シェア ・自己投与薬の世界市場規模 2016年-2021年：種類別（注射薬、吸入薬、経皮吸収薬） ・自己投与薬の世界市場規模 2016年-2021年：用途別（心血管疾患、糖尿病、骨粗鬆症、疼痛管理、ホルモン補充療法、その他） ・自己投与薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・自己投与薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Self-administered Drugs will have significant change from previous year. By the most conservative estimates of global Self-administered Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Self-administered Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Self-administered Drugs market by product type, application, key manufacturers and...
  • 世界のアイケア製品市場予測 2021年-2026年
    LPI21MY9530 / LP Information / 2021年5月 / LPインフォメーション社の「アイケア製品の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、抗生物質、ホルモン、人工涙液、その他など、用途別には、眼病、アイケア、その他などにセグメント区分してまとめました。アイケア製品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・アイケア製品の世界市場概要（サマリー） ・アイケア製品の企業別販売量・売上 ・アイケア製品の企業別市場シェア ・アイケア製品の世界市場規模 2016年-2021年：種類別（抗生物質、ホルモン、人工涙液、その他） ・アイケア製品の世界市場規模 2016年-2021年：用途別（眼病、アイケア、その他） ・アイケア製品の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・アイケア製品のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Eye Care Product will have significant change from previous year. By the most conservative estimates of global Eye Care Product market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Eye Care Product market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Eye Care Product market by product type,...
  • 世界の抗消化性潰瘍薬市場予測 2021年-2026年
    LPI21MY9411 / LP Information / 2021年5月 / LPインフォメーション社の「抗消化性潰瘍薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬など、用途別には、胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）などにセグメント区分してまとめました。抗消化性潰瘍薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗消化性潰瘍薬の世界市場概要（サマリー） ・抗消化性潰瘍薬の企業別販売量・売上 ・抗消化性潰瘍薬の企業別市場シェア ・抗消化性潰瘍薬の世界市場規模 2016年-2021年：種類別（プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬） ・抗消化性潰瘍薬の世界市場規模 2016年-2021年：用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）） ・抗消化性潰瘍薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗消化性潰瘍薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Peptic Ulcer Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti Peptic Ulcer Drugs...
  • 世界のエリキュース市場予測 2021年-2026年
    LPI21MY9515 / LP Information / 2021年5月 / LPインフォメーション社の「エリキュースの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、2.5mg、5mgなど、用途別には、深部静脈血栓症（DVT）、肺塞栓症（PE）などにセグメント区分してまとめました。エリキュースのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・エリキュースの世界市場概要（サマリー） ・エリキュースの企業別販売量・売上 ・エリキュースの企業別市場シェア ・エリキュースの世界市場規模 2016年-2021年：種類別（2.5mg、5mg） ・エリキュースの世界市場規模 2016年-2021年：用途別（深部静脈血栓症（DVT）、肺塞栓症（PE）） ・エリキュースの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・エリキュースのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Eliquis will have significant change from previous year. By the most conservative estimates of global Eliquis market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Eliquis market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Eliquis market by product type, application, key manufacturers and key regions and countries....
  • 世界のプロテインC濃縮物市場予測 2021年-2026年
    LPI21MY9561 / LP Information / 2021年5月 / LPインフォメーション社の「プロテインC濃縮物の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、1000IU、500IUなど、用途別には、病院、診療所などにセグメント区分してまとめました。プロテインC濃縮物のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・プロテインC濃縮物の世界市場概要（サマリー） ・プロテインC濃縮物の企業別販売量・売上 ・プロテインC濃縮物の企業別市場シェア ・プロテインC濃縮物の世界市場規模 2016年-2021年：種類別（1000IU、500IU） ・プロテインC濃縮物の世界市場規模 2016年-2021年：用途別（病院、診療所） ・プロテインC濃縮物の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・プロテインC濃縮物のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Protein C Concentrate will have significant change from previous year. By the most conservative estimates of global Protein C Concentrate market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Protein C Concentrate market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Protein C Concentrate market by product type,...
  • 世界のフィダキソマイシン市場予測 2021年-2026年
    LPI21MY9535 / LP Information / 2021年5月 / LPインフォメーション社の「フィダキソマイシンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度：90％、純度：95％、その他など、用途別には、病院、小売薬局などにセグメント区分してまとめました。フィダキソマイシンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・フィダキソマイシンの世界市場概要（サマリー） ・フィダキソマイシンの企業別販売量・売上 ・フィダキソマイシンの企業別市場シェア ・フィダキソマイシンの世界市場規模 2016年-2021年：種類別（純度：90％、純度：95％、その他） ・フィダキソマイシンの世界市場規模 2016年-2021年：用途別（病院、小売薬局） ・フィダキソマイシンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・フィダキソマイシンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Fidaxomicin will have significant change from previous year. By the most conservative estimates of global Fidaxomicin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Fidaxomicin market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Fidaxomicin market by product type, application, key manufacturers and key regions and countries....
  • 世界の第XIII因子濃縮物市場予測 2021年-2026年
    LPI21MY9532 / LP Information / 2021年5月 / LPインフォメーション社の「第XIII因子濃縮物の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、1000IU、1600IUなど、用途別には、病院、クリニックなどにセグメント区分してまとめました。第XIII因子濃縮物のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・第XIII因子濃縮物の世界市場概要（サマリー） ・第XIII因子濃縮物の企業別販売量・売上 ・第XIII因子濃縮物の企業別市場シェア ・第XIII因子濃縮物の世界市場規模 2016年-2021年：種類別（1000IU、1600IU） ・第XIII因子濃縮物の世界市場規模 2016年-2021年：用途別（病院、クリニック） ・第XIII因子濃縮物の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・第XIII因子濃縮物のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Factor XIII Concentrate will have significant change from previous year. By the most conservative estimates of global Factor XIII Concentrate market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Factor XIII Concentrate market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Factor XIII Concentrate market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆